These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12800227)

  • 1. Loss of fragile histidine triad protein in human hepatocellular carcinoma.
    Zhao P; Song X; Nin YY; Lu YL; Li XH
    World J Gastroenterol; 2003 Jun; 9(6):1216-9. PubMed ID: 12800227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
    Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
    World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma.
    Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
    Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions.
    Hao XP; Willis JE; Pretlow TG; Rao JS; MacLennan GT; Talbot IC; Pretlow TP
    Cancer Res; 2000 Jan; 60(1):18-21. PubMed ID: 10646844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHIT mRNA and protein expression in hepatocellular carcinoma.
    Kannangai R; Sahin F; Adegbola O; Ashfaq R; Su GH; Torbenson M
    Mod Pathol; 2004 Jun; 17(6):653-9. PubMed ID: 15060557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fragile histidine triad gene transduction on proliferation and apoptosis of human hepatocellular carcinoma cells.
    Xu RH; Zheng LY; He DL; Tong J; Zheng LP; Zheng WP; Meng J; Xia LP; Wang CJ; Yi JL
    World J Gastroenterol; 2008 Jun; 14(23):3754-8. PubMed ID: 18595145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
    Zhao P; Lu Y; Zhong M; Liu L; Li B
    Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of fragile histidine triad expression in colorectal carcinoma.
    Zhao P; Lu Y; Hu Y; Zhong M; Li Z; Li X
    Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):124-7. PubMed ID: 12419158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
    Yao CC; Lin CY; Hu MB
    Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
    Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
    Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of abnormal transcripts of the FHIT (fragile histidine triad) gene in ovarian carcinoma.
    Mandai M; Konishi I; Kuroda H; Nanbu K; Matsushita K; Yura Y; Hamid AA; Mori T
    Eur J Cancer; 1998 Apr; 34(5):745-9. PubMed ID: 9713284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
    Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
    Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings.
    Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
    Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
    J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma.
    Guerin LA; Hoffman HT; Zimmerman MB; Robinson RA
    Arch Pathol Lab Med; 2006 Feb; 130(2):158-64. PubMed ID: 16454554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer.
    Rocco A; Schandl L; Chen J; Wang H; Tulassay Z; McNamara D; Malfertheiner P; Ebert MP
    J Cancer Res Clin Oncol; 2003 Feb; 129(2):84-8. PubMed ID: 12669232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: a poor prognostic factor.
    Krivak TC; McBroom JW; Seidman J; Venzon D; Crothers B; MacKoul PJ; Rose GS; Carlson JW; Birrer MJ
    Cancer Res; 2001 Jun; 61(11):4382-5. PubMed ID: 11389064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of FHIT protein expression in gastric adenocarcinoma patients.
    Zhao P; Liu W; Lu YL
    World J Gastroenterol; 2005 Sep; 11(36):5735-8. PubMed ID: 16237777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma.
    Koda M; Yashima K; Kawaguchi K; Andachi H; Hosoda A; Shiota G; Ito H; Murawaki Y
    Cancer Lett; 2003 Sep; 199(2):131-8. PubMed ID: 12969785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.